Web-based Genetic Research on Lupus

NCT02530944

Last updated date
Study Location
Www.23Andme.Com/Lupus
Mountain View, California, 94041, United States
Contact
1-800-718-1021

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Systemic Lupus Erythematosus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
6 + years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- diagnosed with lupus by a qualified physician.

- consents to have 23andMe (via a partner) contact the physician to obtain medical record information

- willing to submit a saliva sample for DNA testing and complete online surveys related to condition

- at least 6 years old (minors under 18 require parental consent to enroll)

- access to the internet

- resides in the United States

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


-

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Systemic Lupus ErythematosusBalancing Lupus Experiences With Stress Strategies
NCT01351662
  1. Charleston, South Carolina
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Systemic Lupus ErythematosusBiomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831
  1. Oklahoma City, Oklahoma
  2. Collegeville, Pennsylvania
ALL GENDERS
14 Years+
years
MULTIPLE SITES
Systemic Lupus ErythematosusWeb-based Genetic Research on Lupus
NCT02530944
  1. Mountain View, California
ALL GENDERS
6 Years+
years
MULTIPLE SITES
Systemic Lupus ErythematosusAn Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus
NCT00432354
  1. Chia-Yi,
  2. Chia-yi,
ALL GENDERS
16 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title Web-based Genetic Research on Lupus
Official Title Not Provided
Brief Summary The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.
Detailed Description Lupus is a difficult disease to diagnose and one that's difficult to manage, given the lack of specific medicines to treat lupus and the side-effects of current medications. The investigators believe genetics may play a critical role in developing better lupus diagnoses and treatments. If individuals are eligible to participate, the investigators will send a 23andMe DNA saliva kit at no cost. Participants will be asked to take a 15 minute online survey with questions about their lupus experience, symptoms and response to treatments, in addition to five additional bi-monthly short surveys and one final study survey during the 12-month participation. Learn more and join the lupus study today: https://www.23andme.com/lupus/
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
Saliva samples are collected for DNA analysis
Sampling Method Non-Probability Sample
Study Population Community Sample
Condition Systemic Lupus Erythematosus
Intervention Not Provided
Study Groups/Cohorts Lupus patients
People diagnosed with Systemic Lupus Erythematosus by a physician
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: August 20, 2015)
5000
Original Estimated Enrollment Same as current
Actual Study Completion Date October 31, 2017
Actual Primary Completion Date October 31, 2017   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • diagnosed with lupus by a qualified physician.
  • consents to have 23andMe (via a partner) contact the physician to obtain medical record information
  • willing to submit a saliva sample for DNA testing and complete online surveys related to condition
  • at least 6 years old (minors under 18 require parental consent to enroll)
  • access to the internet
  • resides in the United States

Exclusion Criteria:

-

Sex/Gender
Sexes Eligible for Study:All
Ages 6 Years and older   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT02530944
Other Study ID Numbers 23andMe_SLE001
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party 23andMe, Inc.
Study Sponsor 23andMe, Inc.
Collaborators Pfizer
Investigators Not Provided
PRS Account 23andMe, Inc.
Verification Date January 2018